Pharmacokinetics of felodipine in patients with liver disease.

Pharmacokinetics of felodipine in patients with liver disease.

Item
http://www.wikidata.org/entity/Q42646696
A population study of the pharmacokinetics of felodipineReduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosis.Efficacy and safety of felodipine, a new dihydropyridine calcium channel blocker, in elderly hypertensive patients.The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humansIntestinal permeability and its relevance for absorption and elimination.A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.A Prediction Model of Drug Exposure in Cirrhotic Patients According to Child-Pugh Classification.Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation.Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine.
P2860

Pharmacokinetics of felodipine in patients with liver disease.

Item
http://www.wikidata.org/entity/Q42646696
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Pharmacokinetics of felodipine in patients with liver disease.
@en
Pharmacokinetics of felodipine in patients with liver disease.
@nl
type
label
Pharmacokinetics of felodipine in patients with liver disease.
@en
Pharmacokinetics of felodipine in patients with liver disease.
@nl
prefLabel
Pharmacokinetics of felodipine in patients with liver disease.
@en
Pharmacokinetics of felodipine in patients with liver disease.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Pharmacokinetics of felodipine in patients with liver disease.
@en
P2093
P2888
P304
P31
P356
P433
P478
P577
P698